Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alistair N Lumb

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Diabetes Care|November 20, 2025
Now Is the Time to Remove Barriers to AID Treatment for Those With Detectable C-PeptideAlistair N Lumb
Current Opinion in Endocrinology, Diabetes, and Obesity|March 21, 2009
Diabetes management for intense exerciseAlistair N Lumb, Ian W Gallen
Diabetic Medicine : a Journal of the British Diabetic Association|February 25, 2009
Treatment of HNF1-alpha MODY with the DPP-4 inhibitor Sitagliptin(1)Alistair N Lumb, Ian W Gallen
The Lancet. Diabetes & Endocrinology|January 28, 2017
Exercise management in type 1 diabetes: a consensus statementMichael C Riddell, Ian W Gallen, Carmel E Smart, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Diabetes Care|November 20, 2025
Now Is the Time to Remove Barriers to AID Treatment for Those With Detectable C-PeptideAlistair N Lumb
Current Opinion in Endocrinology, Diabetes, and Obesity|March 21, 2009
Diabetes management for intense exerciseAlistair N Lumb, Ian W Gallen
Diabetic Medicine : a Journal of the British Diabetic Association|February 25, 2009
Treatment of HNF1-alpha MODY with the DPP-4 inhibitor Sitagliptin(1)Alistair N Lumb, Ian W Gallen
The Lancet. Diabetes & Endocrinology|January 28, 2017
Exercise management in type 1 diabetes: a consensus statementMichael C Riddell, Ian W Gallen, Carmel E Smart, et al.
Pageof 1